Evaluation of Partial and Total Femoral Replacement

Evaluation of Partial and Total Femoral Replacement Treated in a Single Orthopedic Centre

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03045536

Acronym

EFeRe

Enrollment

Registered

2017-02-07

Start date

2016-01-01

Completion date

2019-04-01

Last updated

2017-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Survival, Prostheses

Brief summary

Several surgical options for the reconstruction of massive bone defects have been described and include biologic methods with autografts and allografts, and the use of tumor endoprostheses (total femoral replacement, TFR). Several types of modular TFR are available, but nevertheless unpredictable outcomes and high complication rates have been described from most authors. The aim of the present study was to compare complication rates after TFR performed with modular total femur prosthesis MML (Fa. ESKA/Orthodynamics) in patients with and without malignant disease.

Interventions

DEVICEMML (Fa. ESKA/Orthodynamics)

Classification of complications according to MSTS

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 90 Years

Inclusion criteria

* Total or partial femoral replacement

Exclusion criteria

* Failure of device

Design outcomes

Primary

Measure	Time frame	Description
Survival of device	2 years	Any device-related complications are defined failure

Countries

Germany

Contacts

Primary Contactnorbert harrasser

norbert.harrasser@gmx.net15232716657

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026